JESSICA SETTINERI: Open Payments
NPI 1528766268 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,581 in 208 payments from 25 companies in 2025. Trend: 2023 $2,872 · 2024 $7,023 · 2025 $4,581
Food & beverage: $4,581
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $913 |
| ABBVIE INC. | 30 | $515 |
| PFIZER INC. | 25 | $378 |
| SK Life Science, Inc. | 9 | $268 |
| Biogen, Inc. | 9 | $221 |
| JAZZ PHARMACEUTICALS INC. | 5 | $221 |
| Axsome Therapeutics, Inc. | 5 | $214 |
| CATALYST PHARMACEUTICALS, INC. | 13 | $212 |
| Neurelis, Inc. | 11 | $210 |
| Eisai Inc. | 11 | $191 |
Products named: Leqembi, NURTEC ODT, Fintepla, QULIPTA, EPIDIOLEX, Briviact, Symbravo, FYCOMPA.
Industry payments across FL — which companies pay providers there.
